Engagement

Media Monitoring

For Journalists

BlueLys

End of Day Report On: (OTC:AMBS), (PINK:SRGE), (PINK:GWBU), (PINK:MJNA)

New York, NY -- (ReleaseWire) -- 11/05/2012 --Amarantus BioSciences Inc. (OTC:AMBS) stock closed its latest trading session at $0.05, up 94.64 percent from its previous close of $0.03. However, its today’s volume of 46.294 shares was significantly higher than its usual trading volume of 699k shares. The stock opened the session at $0.03 and touched its highest price point at $0.06. Amarantus BioSciences stock’s lowest price point for the session stood at $0.03. The stock’s MACD chart shows bullish trend in the short term. However, on down side its first support level is at $0.04. Upon breaching this level, the stock may fall to $0.03 level.
Find out if AMBS could maintain today’s bullish approach by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=AMBS

Southridge Entpr (PINK:SRGE) stock closed its latest trading session at $0.01, up 50.00 percent from its previous close of $0.01. The stock rose with the volume of 111.09 million, about 4 times higher than its usual volume of 27.94 million shares. Southridge stock opened the session at $0.01 and touched its highest price point at $0.02. Its lowest price point for the session stood at $0.01. The stock is currently in the bullish mode and is likely to continue the trend as shown by its MACD chart.
Find out what else could be in store for SRGE by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=SRGE

Great Wall Builders Ltd. (PINK:GWBU) traded in the range of $0.01 and $0.04 during its latest trading session. The stock had opened at $0.01 and closed at $0.03, up 160.87 percent from its previous close of $0.01. Despite its up movement, the stock’s MACD chart shows neutral trend and the stock may tumble down to $0.02 level in the coming session. The stock is also trading below its long term moving average price of $0.06, which hints at bearish trend. The negative trend is likely to continue for the mid term time period. However, on upside, the stock is expected to face resistance at $0.19 level.
Find out when could be the best moment to trade GWBU here: http://www.wallstreetreport.net/market-scan/?symbol=GWBU

Medical Marijuana Inc. (PINK:MJNA) traded in the range of $0.10 and $0.13 during its latest trading session. The stock had opened at $0.13 and closed at $0.12, down 3.15 percent from its previous close of $0.13 with heavy volume. Medical Marijuana recorded the volume of 13.490 million shares. Its average daily trading volume stands at 5.472 million shares. The stock price is trading in line with its short term moving average price of $0.12and above long term moving average price of $0.08. The stock is likely to remain bullish in short term time frame. Medical Marijuana may find its first support level at $0.10.
Find out where MJNA could be heading by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=MJNA

About WallStreetReport.net
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors you to be part of the Free VIP membership.

Disclosure
WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.